Price $80.99 |
Market Cap
16.32B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
35.5
|
P/B
3.27
|
P/S
4.2
|
Dividend %
-
|
|
P/CF
43.7
|
P/FCF
18.9
|
Op. Cash Flow
961.1K
|
FCF
3.6
|
|
Op. Margin
16.80%
|
Net Margin
12.00%
|
ROE
9.50%
|
ROI
17.50%
|
|
ROA
5.20%
|
EPS Growth
-67.40%
|
Current Ratio
4.1
|
Debt/Equity
58.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.03 | - | - | 6.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
